Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cancer Biology
100%
Leiomyosarcoma
100%
Understanding of Cancer
100%
Sarcoma
58%
Tumor Protein p53 (TP53)
16%
Soft Tissue Sarcoma
16%
Germline mutation
16%
DNA Repair
16%
New Therapies
16%
Multi-institutional
16%
Translational Research
16%
High-functioning
8%
Doxorubicin
8%
Peripheral Blood
8%
Quality of Life
8%
Clinical Trials
8%
Genetic Epidemiology
8%
American Adults
8%
Ultrarare
8%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
8%
Resistance Mechanism
8%
Older Adults
8%
Tumor Fragments
8%
Lymphoma
8%
Tumor Evolution
8%
Accurate Assessment
8%
Circulating Tumor DNA (ctDNA)
8%
Developmental Projects
8%
Epidemiology
8%
Drug Development
8%
Cancer Genetics
8%
Institutional Initiatives
8%
Malignancy
8%
Collaborative Initiatives
8%
Undifferentiated Pleomorphic Sarcoma
8%
Epidemiology Study
8%
P53 Gene
8%
Chromosomal Instability
8%
New Targets
8%
Clinical Prevalence
8%
Dedifferentiated Liposarcoma (DDLPS)
8%
Myxofibrosarcoma
8%
Li-Fraumeni
8%
Clinical Response
8%
DNA Repair Genes
8%
Tumor Burden
8%
Mesodermal
8%
Rare Tumors
8%
Uterine Leiomyosarcoma
8%
Malignant Tumor
8%
Leukemia
8%
Liquid Biopsy
8%
African American
8%
Somatic mutation
8%
Li-Fraumeni Syndrome
8%
Biological Significance
8%
Career Enhancement
8%
Genetic Vulnerability
8%
Clinical Biomarkers
8%
Phase 1/2 Clinical Trial
8%
Advancement of Knowledge
8%
Diverse Groups
8%
Clinical Behavior
8%
Medicine and Dentistry
Leiomyosarcoma
100%
Cancer Pathobiology
100%
Genetics
100%
Connective Tissue Cancer
61%
DNA Repair
23%
Soft Tissue Sarcoma
15%
Translational Research
15%
Cancer
15%
Germline Mutation
15%
Neoplasm
15%
Dedifferentiated Liposarcoma
7%
Chloroplast DNA
7%
Cancer Genetics
7%
Li Fraumeni
7%
Clinical Research
7%
Repair Gene
7%
Genetic Epidemiology
7%
Chromosomal Instability
7%
Liquid Biopsy
7%
Epidemiology Investigation
7%
Leukemia
7%
Doxorubicin
7%
Prevalence
7%
Low Drug Dose
7%
Rare Tumor
7%
Somatic Mutation
7%
Quality of Life
7%
Pathogenesis
7%
Biological Marker
7%
Li-Fraumeni Syndrome
7%